Log In
Thursday 27th October 2016

US debates cancer vaccine

31st January 2007

04092006_cervical_cancer1.jpgThe development of the vaccine Gardasil, which protects against the virus which causes cervical cancer, has sparked widespread debate in the United States over whether it should be made compulsory for young schoolgirls.

Manufacturers Merck & Co. are lobbying for state laws mandating the immunisation programme, but critics say it would encourage premarital sex.

Currently, at least 18 states are debating whether to make Gardasil compulsory.

Approved by the federal government in July, the vaccine protects girls and women against strains of the human papillomavirus (HPV) responsible for most types of cervical cancer.

Experts recommend vaccination takes place at ages 11 and 12, before girls become sexually active.

So far, not a single state has added it to its list of mandatory immunisations.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2016